Pesquisa | BVS IEC

1.

Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes.

Finer, Nick.

Diabetes Obes Metab ; 24 Suppl 2: 44-54, 2022 02.

Artigo em Inglês | MEDLINE | ID: mdl-34622555

2.

Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.

Zomer, Ella; Leach, Rachel; Trimmer, Christine; Lobstein, Tim; Morris, Stephen; James, William P; Finer, Nick.

Diabetes Obes Metab ; 19(1): 118-124, 2017 01.

Artigo em Inglês | MEDLINE | ID: mdl-27649286

3.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

James, W Philip T; Caterson, Ian D; Coutinho, Walmir; Finer, Nick; Van Gaal, Luc F; Maggioni, Aldo P; Torp-Pedersen, Christian; Sharma, Arya M; Shepherd, Gillian M; Rode, Richard A; Renz, Cheryl L.

N Engl J Med ; 363(10): 905-17, 2010 Sep 02.

Artigo em Inglês | MEDLINE | ID: mdl-20818901

4.

Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24-Hour Holter Electrocardiogram Recordings.

Skovgaard, Dorthe; Haahr, Poul-Martin; Lester, Robert; Clark, Katherine; Paglialunga, Sabina; Finer, Nick; Friedrichsen, Martin H; Hjerpsted, Julie B; Engelmann, Mads D M.

J Clin Pharmacol ; 63(5): 539-543, 2023 05.

Artigo em Inglês | MEDLINE | ID: mdl-36524539

5.

Future directions in obesity pharmacotherapy.

Finer, Nick.

Eur J Intern Med ; 93: 13-20, 2021 11.

Artigo em Inglês | MEDLINE | ID: mdl-34024701

6.

Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database.

Reges, Orna; Dicker, Dror; Haase, Christiane L; Finer, Nick; Karpati, Tomas; Leibowitz, Morton; Satylganova, Altynai; Feldman, Becca.

Obes Sci Pract ; 7(2): 148-158, 2021 Apr.

Artigo em Inglês | MEDLINE | ID: mdl-33841884

7.

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period.

Weeke, Peter; Andersson, Charlotte; Fosbøl, Emil L; Brendorp, Bente; Køber, Lars; Sharma, Arya M; Finer, Nick; James, Philip T; Caterson, Ian D; Rode, Richard A; Torp-Pedersen, Christian.

BMC Endocr Disord ; 10: 3, 2010 Feb 26.

Artigo em Inglês | MEDLINE | ID: mdl-20184783

8.

A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database.

Reges, Orna; Leibowitz, Morton; Hirsch, Avital; Dicker, Dror; Finer, Nick; Haase, Christiane Lundegaard; Satylganova, Altynai; Leventer-Roberts, Maya; Feldman, Becca.

Isr J Health Policy Res ; 9(1): 32, 2020 06 24.

Artigo em Inglês | MEDLINE | ID: mdl-32580788

9.

Sarcopenic obesity: under recognised and over treated?

Finer, Nick.

Clin Med (Lond) ; 14(4): 454, 2014 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-25099857

10.

Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children.

Dangardt, Frida; Charakida, Marietta; Georgiopoulos, Georgios; Chiesa, Scott T; Rapala, Alicja; Wade, Kaitlin H; Hughes, Alun D; Timpson, Nicholas J; Pateras, Konstantinos; Finer, Nick; Sattar, Naveed; Davey Smith, George; Lawlor, Debbie A; Deanfield, John E.

Lancet Child Adolesc Health ; 3(7): 474-481, 2019 07.

Artigo em Inglês | MEDLINE | ID: mdl-31126896

11.

Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

Maggioni, Aldo P; Caterson, Ian; Coutinho, Walmir; Finer, Nick; Gaal, Luc Van; Sharma, Arya M; Torp-Pedersen, Christian; Bacher, Peter; Shepherd, Gillian; Sun, Rui; James, Philip.

J Cardiovasc Pharmacol ; 52(5): 393-402, 2008 Nov.

Artigo em Inglês | MEDLINE | ID: mdl-19033818

12.

Engaging patients, clinicians and health funders in weight management: the Counterweight Programme.

McQuigg, Maria; Brown, Jenny E; Broom, J Iain; Laws, Rachel A; Reckless, John P D; Noble, Paula A; Kumar, Sudhesh; McCombie, E Louise; Lean, Mike E J; Lyons, G Felicity; Mongia, Sarika; Frost, Gary S; Quinn, Marney F; Barth, Julian H; Haynes, Sarah M; Finer, Nick; Haslam, David W; Ross, Hazel M; Hole, David J; Radziwonik, Steven.

Fam Pract ; 25 Suppl 1: i79-86, 2008 Dec.

Artigo em Inglês | MEDLINE | ID: mdl-19042914

13.

Action on obesity: comprehensive care for all.

Wass, John; Finer, Nick.

Clin Med (Lond) ; 13(1): 4-5, 2013 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-23472483

14.

The effects of Ramadan fasting on activity and energy expenditure.

Lessan, Nader; Saadane, Ilham; Alkaf, Budour; Hambly, Catherine; Buckley, Adam J; Finer, Nick; Speakman, John R; Barakat, Maha T.

Am J Clin Nutr ; 107(1): 54-61, 2018 01 01.

Artigo em Inglês | MEDLINE | ID: mdl-29381798

15.

Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.

López, Miguel; Lelliott, Christopher J; Tovar, Sulay; Kimber, Wendy; Gallego, Rosalía; Virtue, Sam; Blount, Margaret; Vázquez, Maria J; Finer, Nick; Powles, Trevor J; O'Rahilly, Stephen; Saha, Asish K; Diéguez, Carlos; Vidal-Puig, Antonio J.

Diabetes ; 55(5): 1327-36, 2006 May.

Artigo em Inglês | MEDLINE | ID: mdl-16644689

16.

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

Scheen, André J; Finer, Nick; Hollander, Priscilla; Jensen, Michael D; Van Gaal, Luc F.

Lancet ; 368(9548): 1660-72, 2006 Nov 11.

Artigo em Inglês | MEDLINE | ID: mdl-17098084

17.

The comparative effects of bariatric surgery on weight and type 2 diabetes.

Levy, Pierre; Fried, Martin; Santini, Ferruccio; Finer, Nick.

Obes Surg ; 17(9): 1248-56, 2007 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-18074502

18.

Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.

Svensson, Johan; Finer, Nick; Bouloux, Pierre; Bevan, John; Jonsson, Björn; Mattsson, Anders F; Lundberg, Mikael; Harris, Philip E; Koltowska-Häggström, Maria; Monson, John P.

Growth Horm IGF Res ; 17(1): 67-76, 2007 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-17223598

19.

A new Editor-in-Chief.

Finer, Nick.

Clin Obes ; 12(5): e12544, 2022 10.

Artigo em Inglês | MEDLINE | ID: mdl-35883278

20.

Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial.

Maggioni, Aldo P; Caterson, Ian D; Urso, Renato; Coutinho, Walmir; Finer, Nick; Van Gaal, Luc; Legler, Udo F; Sharma, Arya M; Seimon, Radhika V; Sweeting, Arianne; Torp-Pedersen, Christian; James, William Philip T.

J Cardiovasc Med (Hagerstown) ; 18(3): 144-151, 2017 Mar.

Artigo em Inglês | MEDLINE | ID: mdl-28002198

BVS IEC

Instituto Evandro Chagas

Configurar filtros

Sua seleção (0)

Formato de exportação:

Exportar:

Weight loss interventions and nonalcoholic fatty liver disease: Optimizing liver outcomes.

Effectiveness and cost-effectiveness of interventions that cause weight loss and reduce the risk of cardiovascular disease.

Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects.

Prevalence of Baseline Cardiac Arrhythmias in Participants with Overweight or Obesity in Phase 1 Clinical Trials: Analysis of 24-Hour Holter Electrocardiogram Recordings.

Future directions in obesity pharmacotherapy.

Body mass index trajectories among people with obesity and association with mortality: Evidence from a large Israeli database.

The weight lowering effect of sibutramine and its impact on serum lipids in cardiovascular high risk patients with and without type 2 diabetes mellitus - an analysis from the SCOUT lead-in period.

A comprehensive descriptive assessment of obesity related chronic morbidity and estimated annual cost burden from a population-based electronic health record database.

Sarcopenic obesity: under recognised and over treated?

Association between fat mass through adolescence and arterial stiffness: a population-based study from The Avon Longitudinal Study of Parents and Children.

Tolerability of sibutramine during a 6-week treatment period in high-risk patients with cardiovascular disease and/or diabetes: a preliminary analysis of the Sibutramine Cardiovascular Outcomes (SCOUT) Trial.

Engaging patients, clinicians and health funders in weight management: the Counterweight Programme.

Action on obesity: comprehensive care for all.

The effects of Ramadan fasting on activity and energy expenditure.

Tamoxifen-induced anorexia is associated with fatty acid synthase inhibition in the ventromedial nucleus of the hypothalamus and accumulation of malonyl-CoA.

Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study.

The comparative effects of bariatric surgery on weight and type 2 diabetes.

Growth hormone (GH) replacement therapy in GH deficient adults: predictors of one-year metabolic and clinical response.

A new Editor-in-Chief.

Relation between weight loss and causes of death in patients with cardiovascular disease: finding from the SCOUT trial.